Expression of polycomb group protein EZH2 in nevi and melanoma
dc.contributor.author | McHugh, Jonathan B. | en_US |
dc.contributor.author | Fullen, Douglas R. | en_US |
dc.contributor.author | Ma, Linglei | en_US |
dc.contributor.author | Kleer, Celina G. | en_US |
dc.contributor.author | Su, Lyndon D. | en_US |
dc.date.accessioned | 2010-06-01T21:32:50Z | |
dc.date.available | 2010-06-01T21:32:50Z | |
dc.date.issued | 2007-08 | en_US |
dc.identifier.citation | McHugh, Jonathan B.; Fullen, Douglas R.; Ma, Linglei; Kleer, Celina G.; Su, Lyndon D. (2007). "Expression of polycomb group protein EZH2 in nevi and melanoma." Journal of Cutaneous Pathology 34(8): 597-600. <http://hdl.handle.net/2027.42/74600> | en_US |
dc.identifier.issn | 0303-6987 | en_US |
dc.identifier.issn | 1600-0560 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/74600 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17640228&dopt=citation | en_US |
dc.format.extent | 334898 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | Blackwell Munksgaard 2007 | en_US |
dc.title | Expression of polycomb group protein EZH2 in nevi and melanoma | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Dermatology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pathology, University of Michigan, Ann Arbor, MI, USA | en_US |
dc.identifier.pmid | 17640228 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/74600/1/j.1600-0560.2006.00678.x.pdf | |
dc.identifier.doi | 10.1111/j.1600-0560.2006.00678.x | en_US |
dc.identifier.source | Journal of Cutaneous Pathology | en_US |
dc.identifier.citedreference | Laibile G, Wolf A, Dorn R, et al. Mammalian homologues of the polycomb-group gene enhancer of zeste mediate gene silencing in Drosophila heterochromatin and at S. cerevisae telomeres. EMBO J 1997; 16: 3219. | en_US |
dc.identifier.citedreference | Simon JA, Tamkun JW. Programming off and on states in chromatin: mechanisms of polycomb and trithorax group complexes. Curr Opin Genet Dev 2002; 12: 210. | en_US |
dc.identifier.citedreference | Tang X, Milyavsky M, Shats I, Erez N, Goldfinger N, Rotter V. Activated p53 suppresses the histone methyltransferase EZH2 gene. Oncogene 2004; 23: 5759. | en_US |
dc.identifier.citedreference | Bracken AP, Pasini D, Capra M, Prosperini E, Colli E, Helin K. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J 2003; 22: 5323. | en_US |
dc.identifier.citedreference | Raaphorst FM, van Kemenade FJ, Blokzijl T, et al. Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin’s disease. Am J Pathol 2000; 157: 709. | en_US |
dc.identifier.citedreference | Varambally S, Dhanasekaran SM, Zhou M, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002; 419: 624. | en_US |
dc.identifier.citedreference | Kleer CG, Cao Q, Varambally S, et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A 2003; 100: 11606. | en_US |
dc.identifier.citedreference | Raaphorst FM, Meijer CJ, Fieret E, et al. Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene. Neoplasia 2003; 5: 481. | en_US |
dc.identifier.citedreference | Sudo T, Utsunomiya T, Mimori K, et al. Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma. Br J Cancer 2005; 92: 1754. | en_US |
dc.identifier.citedreference | Arisan S, Buyuktuncer ED, Palavan-Unsal N, Caskurlu T, Cakir OO, Ergenekon E. Increased expression of EZH2, a polycomb group protein, in bladder carcinoma. Urol Int 2005; 75: 252. | en_US |
dc.identifier.citedreference | Bachmann IM, Halvorsen OJ, Collett K, et al. EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate and breast. J Clin Oncol 2006; 24: 268. | en_US |
dc.identifier.citedreference | Kirmizis A, Bartley SM, Farnham PJ. Identification of the polycomb group protein SU(Z)12 as potential molecular target for human cancer therapy. Mol Cancer Ther 2003; 2: 113. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.